« Previous
Next »
American Journal of Cardiology
Volume 100, Issue 7
, Pages 1109-1113
, 1 October 2007
Impact of In-Stent Restenosis on Death and Myocardial Infarction
References
- . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
- . A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
- . Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol. 2006;98:729–733
- . In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol. 2000;35:1569–1576
- . Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151:1260–1264
- . Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol. 2002;89:491–494
- . Myocardial infarction as a presentation of clinical in-stent restenosis. Circ J. 2006;70:1026–1029
- . Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation. 1993;87:831–840
- . Can we afford to eliminate restenosis? (Can we afford not to?). J Am Coll Cardiol. 2004;43:513–518
- . Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006;295:1253–1263
- . Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295:1264–1273
- Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT). J Am Coll Cardiol. 2004;43:943–949
- Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030–1039
- . Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Am J Cardiol. 2006;98:895–901
- . Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009–1019
- Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008
- Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678
- . REWARDS Registry (Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry)). Am J Cardiol. 2007;100:45–51
PII: S0002-9149(07)01255-6
doi: 10.1016/j.amjcard.2007.05.033
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 100, Issue 7
, Pages 1109-1113
, 1 October 2007
